Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in the unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes EryDex, developed using their proprietary Autologous Intracellular Drug Encapsulation (AIDE) technology platform, which is a novel device combination that uses an automated process designed to encapsulate a drug into the patient’s own red blood cells. The company was founded by Casey Crawford Lynch, Stephen Dominy, and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
36
Frequently Asked Questions
What is Market Cap of Quince Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Quince Therapeutics Inc market cap is $85.94M.
What is the 52-week high for Quince Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Quince Therapeutics Inc 52 week high is $2.45 as of September 23, 2025.
What is the 52-week low for Quince Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Quince Therapeutics Inc 52 week low is $0.69 as of September 23, 2025.
What is Quince Therapeutics Inc stock price today?
Quince Therapeutics Inc stock price today is $1.62.
What was Quince Therapeutics Inc stock price yesterday?
Quince Therapeutics Inc stock price yesterday was $1.60.
What is the PE ratio of Quince Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Quince Therapeutics Inc’s P/E ratio is -1.46.
What is the Price-to-Book ratio of Quince Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Quince Therapeutics Inc P/B ratio is 7.3106.
What is the 50-day moving average of Quince Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Quince Therapeutics Inc 50-day moving average is $1.68.
How many employess does Quince Therapeutics Inc has?
